ClinConnect ClinConnect Logo
Search / Trial NCT07124520

A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue Cance

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Aug 8, 2025

Trial Information

Current as of September 09, 2025

Recruiting

Keywords

Tongue Cancer Oral Tongue Cancer Iopi Lingual Strength Trainer Iowa Oral Performance Instrument Iowa Oral Performance Instrument Tongue Strength Trainer Memorial Sloan Kettering Cancer Center 25 162

ClinConnect Summary

This clinical trial is studying tongue strength and how long the tongue can hold pressure in people with tongue cancer. Researchers are using a special device called the Iowa Oral Performance Instrument (IOPI) to measure how strong the tongue is by checking the pressure it can create. The goal is to better understand tongue function in people who are preparing for surgery to remove part of their tongue due to cancer.

People who might be eligible for this study are adults 18 years and older who are scheduled to have surgery to remove part of their tongue because of cancer. The surgery can be one of several types, but it should not involve removing large parts of the tongue or jawbone. People who have had previous radiation or surgery for mouth or head and neck cancer, or who rely on feeding tubes before surgery, cannot join. If you take part, you will have your tongue strength tested with the IOPI device before and after surgery. This study is currently looking for participants, and it includes both men and women between the ages of 65 and 74.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥18 years old
  • Scheduled to undergo primary surgery for oral tongue cancer (glossectomy types 1 to 3) using any type of closure or reconstruction
  • Exclusion Criteria:
  • Previous radiation therapy to the oral cavity or head and neck
  • Previous surgery for oral cavity cancer
  • Recurrent oral cavity cancer
  • Surgical requirement of extension to involve bone (mandible resection)
  • Subtotal or total glossectomy
  • Feeding tube dependance prior to surgery

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.

Locations

Middletown, New Jersey, United States

Montvale, New Jersey, United States

Harrison, New York, United States

Basking Ridge, New Jersey, United States

Commack, New York, United States

Uniondale, New York, United States

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Louise Cunningham

Principal Investigator

Memorial Sloan Kettering Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported